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fatality after a characterisitic latent period.
Methanol is sometimes used as an ethanol substitute by alcohol abusers.
\ y ]  The shift to alternative motor fuels may significantly increase both acute and chronic 
1----- ' methanol exposures in the general population.
This monograph is one in a series of self-instructional publications designed to increase the primary care 
provider's knowledge of hazardous substances in the environment and to aid in the evaluation of potentially 
exposed patients. See page 21 for more information about continuing medical education credits and continuing 
education units.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each 
section. To benefit fully from this monograph, readers are urged to answer each question when it is presented. 
(Answers to the Pretest and Challenge questions are found on pages 17-19.) The monograph ends with a 
posttest, which can be submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for 
continuing medical education (CME) credit or continuing education units (CEU). See page 21 for further 
instructions on how to receive these credits.
The objectives of this monograph on methanol are to help you:
□  Explain why methanol may be a health hazard
□  Describe the factors contributing to methanol toxicity
□  Identify potential environmental and occupational sources of exposure to methanol
□  Identify evaluation and treatment protocols for persons exposed to methanol















This issue is prepared with the assistance of those who share a common concern for physician education, public 
health, and the environment, including the following organizations: American Academy of Family Physicians 
(AAFP), American Academy of Pediatrics (AAP), American College of Emergency Physicians (ACEP), American 
College of Occupational and Environmental Medicine (ACOEM), American Medical Association (AMA), Associa­
tion of State and Territorial Health Officials (ASTHO), and the Society of Teachers of Family Medicine (STFM). 
Final responsibility for the contents and views expressed in this monograph resides with ATSDR.
Agency for Toxic Substances and Disease Registry 
Project Officer: Teresa Ramsey, MA 
Prepared by DeLima Associates, San Rafael, California, under Contract No. 205-90-0817
Original printing: July 1992
Case Study
A 67-year-old man with headache, nausea, and visual disturbance
During an afternoon visit, you see a 67-year-old man for onset of headache, nausea, and visual disturbance. 
The friend who accompanies him explains that both of them frequent the same senior center and that they have 
been preparing for a fund-raising event during the past 2 days. During this time, the patient spent between 6 and 
9 hours per day reproducing fliers using a “spirit duplicator” (mimeograph machine). This activity took place in a 
small, unventilated room with the patient working alone most of the time.
On questioning, the patient says that he had eye irritation and lightheadedness after the first few hours of 
activity but considered these symptoms to be a minor annoyance. He also had nausea by the end of the first day 
but noted that this cleared overnight. During the second day of activity, he was again troubled by eye irritation, this 
time accompanied by vertigo, tinnitus, visual blurring, and photophobia. He tried to ventilate the room by placing 
a small fan near the door but continued to feel poorly despite a prolonged break. Late in the afternoon his friend 
insisted that he seek medical attention.
The patient is a widower and retired insurance salesman with a smoking history of one pack per day from age 
27 to 62 (none for the last 5 years). He typically consumes a six-pack of beer per day, but he has felt poorly and 
has had no alcohol for the past 10 days. Medical history includes coronary artery bypass surgery at age 63 with 
subsequent medical management of stable angina and a transurethral prostatectomy at age 65 with no recurrence 
of obstructive symptoms. Current medications include nitroglycerine patches used before exercise (with no 
patches used in the previous 4 days) and sublingual nitroglycerine, which he takes rarely. The review of symptoms 
is negative for other cardiopulmonary complaints. There is no family history of glaucoma, myopia, or diabetes 
mellitus.
On examination, the patient is alert and oriented to time, space, and person, although he appears somewhat 
distracted. His breath has a faint solvent-like smell. Vital signs are within normal range with the exception of a 
respiratory rate of 30/minute. The cardiopulmonary examination is unremarkable, but abdominal examination 
reveals mild tenderness in the epigastrium without rebound or guarding. Muscle tone, strength, sensation 
(pinprick, light touch, position sense) and reflexes are symmetrically intact. His gait is unsteady with a wide-based 
stance, and he shows a positive Romberg sign, heel-to-shin, and rapid alternating movements (bilaterally).
Ophthalmologic examination reveals a visual acuity of 20/200 bilaterally despite newly prescribed corrective 
lenses. The conjunctivae appear somewhat injected, nystagmus is present on lateral gaze, and the pupils are large 
and poorly reactive to light. Examination also reveals hyperemia of the optic nerve head with no hemorrhages or 
exudates.
(a) What is the differential diagnosis for this patient?
(b) What additional information would you request regarding the patient’s activities in the last 
2 days?
(c) What consultation(s) would you obtain to help you manage this case?
(d) What type of therapeutic intervention is indicated?




Methanol (methyl alcohol) is a clear, colorless, flammable liquid with 
a faintly pleasant odor. Popularly known as wood alcohol, methanol 
has historically been referred to as wood spirit, wood naphtha, 
pyroligneous spirit, and carbinol. Despite these references to its 
derivation as a wood distillation product, methanol is currently 
produced almost exclusively by synthetic pathways. It ranks 22nd (by 
volume) among chemicals produced in the United States.
The largest quantities of methanol are used for the manufacture of 
other chemicals including methyl methacrylate, acetic acid, ethylene 
glycol, and methyl chloride. Methanol also is added to a variety of 
commercial and consumer products such as windshield washing and 
deicing solutions (35% to 95% concentration), duplicating fluids 
(95% concentration or greater), solid canned fuels (4% concentra­
tion), paint removers, model airplane fuels, and embalming fluids. 
Other methanol uses are as a denaturant for ethanol; as a solvent for 
shellacs, lacquers, adhesives, and inks; and, most recently, as an 
alternative motor fuel. Because methanol is a natural fermentation 
product, its concentration may be up to 300 milligrams per liter 
(mg/L) in wines and higher in brandies and other distilled fruit spirits. 
Although serious methanol toxicity has been most commonly asso­
ciated with ingestions, exposures also occur via inhalation and skin 
absorption, which are a concern in both occupational and household 
settings.
Environmentally, methanol has been detected in concentrations 
ranging from less than 10 parts per billion (ppb) in rural air to nearly 
30 ppb in urban air. If methanol-powered vehicles become more 
prevalent, ambient methanol levels could be thousands of times 
greater in residential and public parking garages. Currently, there is 
no enforceable atmospheric standard for methanol. Increased use of 
methanol as a motor fuel would probably result in the reduction of 
some air pollutants (e.g., particulates and ozone) but an increase in 
others (e.g., formaldehyde). Data regarding methanol levels in 
drinking water are lacking.
Cfialknge
(1 ) In emergency situations, what reference sources could you use to aid in identifying the chemical 
constituents of consumer and commercial products such as the duplicating fluid used in the case 
study?
□  Methanol is used in a variety 
of commercial and consumer 
products.
□  Increased use of methanol 
as a motor fuel may cause 
higher ambient air levels 
and a greater potential for 





According to estimates from the National Institute for Occupational 
Safety and Health (NIOSH), more than 2.5 million persons are 
regularly exposed to methanol on the job. Workers most likely to 
experience inhalation or skin exposures to methanol include book­
binders, bronzers, dyers, foundry workers, gilders, hatmakers, ink 
makers, laboratory technicians, painters, photoengravers, and chemi­
cal manufacturers. In addition, administrative aides or others using 
mimeograph machines may be exposed to methanol, as well as 
workers at refineries, fuel distribution centers, and service stations, 
if they handle methanol-containing fuels.
Householders, hobbyists, and motorists using methanol-containing 
products can be at risk for inhalation exposure; therefore, precau­
tions must be taken to avoid using these products in poorly ventilated 
spaces. In addition, prolonged skin contact with methanol can 
produce systemic effects—a painter developed blindness after 
working in methanol-soaked clothes, and an 8-month-old child with 
a methanol-soaked pad placed on his chest developed signs of 
methanol toxicity.
Historically, the largest number of serious methanol exposures have 
occurred by ingestion. Methanol poisoning has been caused by 
materials such as shellac thinner, duplicator fluid, and denatured 
alcohol that have been drunk directly or have been used to adulterate 
beverages. In addition, about 35,000 gasoline ingestions are re­
ported annually in the United States, most of which occur from fuel 
siphoning. Siphoning accidents could significantly increase the 
number of methanol ingestions if the use of methanol-containing 
automotive fuels becomes widespread.
One step in the metabolic detoxification of methanol is a folic acid- 
dependent process. Consequently, susceptibility to methanol toxic­
ity may be higher among folate-deficient persons. Folate deficiency 
can occur not only in persons consuming inadequate diets, but also 
in those with intestinal malabsorption (e.g., inflammatory bowel 
disease) or hemolytic anemia, or in persons undergoing drug therapy 
(e.g., anticonvulsants, antibiotics). Because alcoholics have a greater 
likelihood of both methanol ingestion and folate deficiency, they may 
be at dual risk for methanol's adverse effects. Up to 10% of the 
population may be folate-deficient.
□  Persons having prolonged 
skin contact with methanol 
are at risk of developing 
severe systemic effects.
□  Persons ingesting adulterated 
alcoholic beverages are at 
great risk of methanol 
toxicity.
□  Folate-deficient persons are 
potentially at increased risk 





Additional information for the case study: During the investigation, you request a listing of the contents 
on the label of the duplicating fluid used by the patient. You learn that it contains greater than 90% 
methanol. You also learn that the patient drank a small amount of the duplicating fluid (about 5 milliliters 
[mL]) on his second day of working at the senior center.
(2) Discuss the factor(s) that may place this patient at increased risk of methanol toxicity.
Biologic Fate
□  Methanol is absorbed well by 
all exposure routes.
□  Methanol is oxidized in the 
liver to formaldehyde, then 
formic acid, which contributes 
to the profound metabolic 
acidosis seen in acute 
methanol poisoning.
□  Most methanol is eliminated 
via the lungs as carbon 
dioxide.
Gastrointestinal absorption of methanol is virtually complete, whereas 
lung retention averages 58%. Dermal absorption may occur If skin is 
abraded or methanol exposure is prolonged. There is evidence that 
methanol absorption through the skin is enhanced in gasollne- 
methanol mixtures. Once absorbed, methanol is distributed with 
total body water.
Metabolism of methanol is a three-step process taking place chiefly 
in the liver. The first metabolic step involves methanol’s oxidation to 
formaldehyde by alcohol dehydrogenase, which is a saturable, rate- 
limiting process (Figure 1, Step 1). In the next step (Figure 1, Step 
2 ), formaldehyde is oxidized by aldehyde dehydrogenase to formic 
acid (or formate, depending upon pH). Since step 2 is rapid, little 
formaldehyde accumulates in the serum. Formic acid, a metabolite 
of formaldehyde, contributes to the development of metabolic acido­
sis both directly (i.e., via its acid load) and indirectly (i.e., through its 
inhibitory effects upon iron-containing cytochromes with subsequent 
accumulation of lactic acid [lactate]). In Step 3, formic acid is 
detoxified to carbon dioxide and water.
Some absorbed methanol is eliminated unchanged via the lungs 
(10% to 20%) and kidneys (about 3%). However, most absorbed 
methanol is oxidatively metabolized (75% to 85%). A small amount 
of the metabolic products Is excreted in the urine as formate, but 
most is exhaled as carbon dioxide. Methanol elimination patterns are 
dose-dependent, with elimination half-lives ranging from 3 hours in 




Figure 1. Methanol metabolism to toxic intermediates—formaldehyde 














CO + H O2 2
Discovery of methanol’s metabolic pathway has led to several 
practical treatments; among them are the therapeutic administration 
of ethanol and folic acid. Alcohol dehydrogenase, the enzyme 
responsible for the first step of methanol metabolism, has an 
approximately ninefold greater affinity for ethanol than for methanol. 
Administration of ethanol blocks the oxidation of methanol, prevent­
ing the lethal synthesis of formaldehyde and formic acid and increas­
ing the amount of methanol that is eliminated unchanged (now 
approximately equal amounts in urine and exhaled breath). Admin­
istration of folic acid and its analogues, which affect Step 3, en­




□  The acute effects of inhaling 
methanol vapor, which are 
similar to those caused by 
many other organic solvents, 
include upper respiratory tract 
irritation and inebriation.
Methanol shares with many other hydrocarbon solvents the ability to 
produce reversible sensory irritation, headache, nausea, and narco­
sis at airborne levels below those producing specific organ system 
pathology. Headaches were a frequent complaint in one study of 
office workers in the vicinity of duplicating machines where airborne 
methanol levels were in the range of 200 to 375 parts per million 
(ppm). In another study, exposed administrative aides were
5
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□  The metabolic products of 
methanol can produce a 
syndrome of delayed-onset 
acidosis, obtundation, visual 
disturbance, and death.
□  Partial or total blindness, 
dementia, or a Parkinson-like 
syndrome are potential 
sequelae in survivors of 
acute methanol intoxication.
□  Chronic exposures to 
methanol have not been 
thoroughly studied, although 
anecdotal reports of chronic 
visual effects have been 
published in the medical 
literature.
significantly more likely to report blurred vision, headache, dizzi­
ness, and nausea than were controls. Workers reported that the 
symptoms improved when they were away from the workplace.
Most methanol-related metabolic and ophthalmologic alterations 
have been associated with exposure through ingestion. Although the 
most frequently cited dosage for a lethal methanol ingestion is 
1 milliliter per kilogram (ml_/kg) of body weight, permanent blindness 
and deaths have been reported with ingestions as low as 0.1 mL/kg 
(6 to 10 mL in adults).
Metabolic Effects
After a characteristic latent period of 6 to 30 hours, severe metabolic 
acidosis may occur in victims of methanol poisoning. The acidosis is 
due to formic acid, and less often, lactic acid. Formic acid is 
metabolically produced from methanol, while lactic acid results from 
hypotension and from formate’s interference with cellular respira­
tion.
Ophthalmologic and Neurologic Effects
Experimental evidence suggests that formate is responsible for optic 
nerve damage in methanol overexposure. In fatal cases, the optic 
nerve shows central necrosis in the distal (orbital) portion with the 
central optic tracts intact. In nonfatal cases, visual function can 
normalize completely after treatment, although central and periph­
eral scotomata or complete blindness may persist, depending on 
several variables. Occasional neurologic sequelae of methanol 
poisoning can include polyneuropathy, a Parkinson-like extrapyra- 
midal syndrome, and mild dementia. Hemorrhages in the putamen 
have been documented on computerized tomography (CT) scan­
ning and on pathologic examination.
Chronic Exposure
Respiratory and Ophthalmologic Effects
Despite methanol’s widespread use, there are few rigorous studies 
of workers chronically exposed to methanol. Some reports can be 
found of permanent visual effects due to chronic inhalation or dermal 
exposure, but many of these reports date to the early part of the 
century and lack exposure data. Inhalation studies in experimental 
animals do not demonstrate significant pathology with chronic expo­
sures at levels up to 50 times the current occupational permissible 
exposure limit (PEL) of 200 ppm. The only consistent effects in rats 
and monkeys exposed for 4 weeks to levels up to 5000 ppm 
methanol vapor were mucoid nasal discharge and upper respiratory 
tract irritation; no ophthalmologic alterations were found. Because 
formic acid is rapidly metabolized and does not accumulate in
6
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experimental animals, they may not be good models for the ophthal­
mologic effects of methanol.
Other Effects
Published data on animal and human developmental effects of 
methanol are limited and inconclusive. One case-control study of 
pregnant women in the workplace shows a possible association 
of fetal central nervous system defects with exposures to a mixed 
solvent that included methanol. The general medical literature 
contains no references to methanol’s carcinogenic potential in 
humans.
Data regarding the 
potential developmental 
effects of methanol 
exposure are 
inconclusive.
Data regarding the 
carcinogenic potential 
of methanol in humans 
are lacking.
CPattenßi
(3) Do the symptoms and appearance of the patient in the case study suggest acute methanol 
intoxication? Explain.
Clinical Evaluation
History and Physical Examination
History-taking in methanol intoxications should focus on exposure 
route. In suspected ingestions, the clinician should ask about the 
consumption of illicit alcoholic beverages (or beverages that may 
have been adulterated) and about other potential accidental or 
intentional ingestion scenarios. In suspected inhalational and der­
mal exposures, emphasis should be placed on identifying specific 
methanol-containing products (e.g., canned fuel, windshield washer 
solution, duplicator fluid, shellac thinner, alternative fuels) and on 
documenting unusual conditions of prolonged and extensive skin 
contact or inhalation. The symptom history should emphasize distur­
bances In visual, neurologic, and gastrointestinal function. The 
physical examination should focus particularly on neurologic status 
and ocular findings.
In cases of suspected 
methanol intoxication, 
the goal is to determine 
exposure route and 




Signs and Symptoms 
Acute Exposure
Persons acutely exposed to high levels of methanol via ingestion, 
inhalation, or extensive skin contact may develop severe metabolic, 
ocular, and neurologic toxicity. The initial intoxicating effects of 
methanol are similarto those of ethanol in producing cognitive slowing 
and cloudy sensorium, which extends to impaired brain stem function 
at very high doses. After a latent period of 12 to 24 hours, methanol 
toxicity may result in progressive visual disturbance and impairment 
of consciousness due to the gradual build-up of toxic metabolites. 
Unusual ocular symptoms, such as a sensation of “being in a 
snowstorm,” may be reported. Ophthalmologic examination may 
reveal central or peripheral visual field defects and dilated pupils that 
react poorly to light but accommodate normally. Erythema of the optic 
nerve may occur, with peripapillar edema early in the course. Rarely, 
flame-shaped hemorrhages may be seen. Necrosis of the distal 
portion of the optic nerve leads to atrophy, which may be evidenced 
by optic nerve pallor days or weeks after exposure.
Chronic Exposure
Persons intermittently or chronically exposed to airborne methanol at 
level methanol exposure are levels Insufficient to cause systemic acidosis may complain of eye 
generally reversible. irritation and visual blurring, upper respiratory irritation, headache,
nausea, and lightheadedness—all of which are reversible under 
these conditions. Chronic short-term cutaneous exposures may re­
sult in skin irritation and defatting. Chronic ingestion of methanol at 
levels documented in commercially distilled beverages or in drinking 
water have not been linked with specific symptoms or pathology.
Laboratory Tests
In light of methanol’s profound metabolic effects, numerous standard 
laboratory tests are useful in documenting acute toxicity. These 
include the following:
Blood methanol and blood ethanol 
Arterial blood gases
Serum electrolytes (Na+, K+, Cl', HCC>3‘ ) and calculation of 
anion gap 
BUN and serum creatinine 
Serum glucose 
Serum ketones
Serum osmolarity and calculation of osmolar gap
Urinalysis
CBC
□  Timely evaluation of a 
patient who may be over­
exposed to methanol is 
essential to prevent severe 
and permanent sequelae.




Although methanol can be detected in both urine and exhaled 
breath, blood methanol levels are more widely available and serve 
as the best predictor of toxicity immediately after acute exposure. 
The normal blood concentration of methanol from endogenous 
sources is less than 0.05 milligrams per deciliter (mg/dL). Generally, 
central nervous system (CNS) effects appear above blood methanol 
levels of 20 mg/dL; ocular symptoms appear above 100 mg/dL; and 
fatalities in untreated patients have occurred in the range of 150 to 
200 mg/dL.
After the latency period, blood methanol level alone is not a reliable 
prognostic indicator because toxicity results from the metabolites. A 
methanol level below 20 mg/dL in a symptomatic patient, for ex­
ample, does not rule out serious intoxication since the methanol may 
already have been completely metabolized to formate. When con­
siderable time has elapsed after ingestion, mortality correlates best 
with severity of acidosis rather than with blood methanol levels.
In the workplace, where intermittent or chronic exposures are likely 
to occur, the American Conference of Governmental Industrial 
Hygienists (ACGIH) recommends a urinary methanol level of less 
than 15 mg/L at the end of an 8-hour workshlft.
Indirect Biologic Indicators
Of methanol’s metabolites, only formate is present in biologic fluids 
at concentrations useful for monitoring exposures. When serum 
formate levels exceed 20 mg/dL, ocular injury and metabolic acido­
sis are likely. In acute intoxications, elevated serum formate concen­
trations can confirm the diagnosis and aid in clinical decisionmaking 
regarding the institution of hemodialysis. However, laboratory tests 
for serum formate levels are not widely available.
The ACGIH considers a urinary formic acid level of less than 80 
milligrams per gram (mg/g) creatinine, obtained preshift at the end 
of a workweek, as indicative of exposures below the 8-hour time- 
weighted average (TWA) of 200 ppm.
The anion gap and osmolar gap aid in the diagnosis of acute 
methanol poisoning. The serum anion gap (AG) may be defined by 
the formula
AG = ( Na+ + K+ ) -  ( Cl" + HC03' )
with all ions measured in milliequivalents per liter (mEq/L). The 
normal anion gap is 12  to 16.
□  Immediately after an 
acute exposure, a blood 
methanol level serves as 
the best predictor of the 
severity of the clinical 
course.
□  Chronic methanol 




□  Formate levels are 
useful as indicators of 
methanol exposure, 
although they are not 
widely available.
□  Both the anion and 
osmolar gaps are 




An approximation of the serum osmolar gap (OG) is most commonly 
defined as
OG = Osmolarity (measured) -  (2 Na+ + [BUN + 2.8] + [Glucose + 1 8 ])
with measured osmolarity expressed in milliosmoles per liter 
(mOsm/L), Na+ in mEq/L, and BUN and glucose in mg/dL. The normal 
osmolar gap is Oto 1 0 .
The conditions that can produce an elevated anion-gap acidosis are 




P Propylene glycol poisoning
I Iron and isoniazid overdoses; inhalants (carbon monoxide, 
cyanide, hydrogen sulfide)
L Lactic acidosis
E Ethanol (alcoholic) ketoacidosis, ethylene glycol poisoning
S Salicylate overdose
Of the various pathophysiologic states and toxic agents listed above, 
only diabetic ketoacidosis, ethanol ketoacidosis, and methanol and 
ethylene glycol poisoning produce elevations of both the anion and 
osmolar gaps. Identification of diabetic ketoacidosis is based on the 
findings of elevated serum glucose and ketones, particularly in a 
person with pre-existing diabetes mellitus. Ethanol ketoacidosis is 
characterized by a history of chronic, excessive ethanol intake with 
anorexia and vomiting and acidosis out of proportion to the apparent 
degree of ketonemia.
Differentiation of methanol and ethylene glycol poisoning is based on 
the exposure history and on specific toxicologic testing. In ethylene 
glycol poisoning, there is an absence of eye complaints; oxalate 
crystals are found in the urine; and hypocalcemia may be present.
Findings that may accompany secondary complications of methanol 
poisoning include myoglobinuric renal failure (with elevations in 
serum creatinine and creatinine phosphokinase (CPK), a positive test 
for occult blood in the urine, and rare or absent red blood cells in the 
urine sediment), pancreatic or salivary gland pathology (with 
hyperamylasemia), and central nervous system pathology (as evi­
denced by diffuse cerebral edema or hemorrhages of the putamen on 
CT scanning). Mean corpuscular volume (MOV) is elevated in severe 
methanol poisoning, probably resulting from a primary increase in red 
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The patient in the case study has a serum sodium of 140, potassium 4.0, chloride 102, and bicarbonate 
10 (all measured in mEq/L). The glucose level is 90 mg/dL, BUN 14 mg/dL, and measured osmolarity 
320 mOsm/L. What is the calculated anion gap? Osmolar gap? Are these gaps consistent with 
methanol poisoning?
(5) What is the differential diagnosis fora wide anion-gap acidosis?
(6) What conditions can produce an elevated serum osmolar gap?
(7) What neuro-ophthalmologic findings might be anticipated in the patient?
Treatment and Management
Acute Exposure
Acute methanol intoxication constitutes a medical emergency. Effec­
tive therapy requires attention to both clinical and laboratory data, as 
well as anticipation of events that may be latent at the time of initial 
examination. Methanol intoxication, like that of ethylene glycol, 
acetaminophen, and lithium, may deceive the clinician by the initial 
lack of severe toxic manifestations.
For recent, suspected methanol ingestions, gut decontamination 
should be carried out even in the absence of clinical or laboratory 
abnormalities. Emesis should be induced if the patient is conscious 
and if a substantial ingestion has occurred within 30 to 45 minutes of 
first medical care; alternatively, gastric lavage may be performed, 
particularly if the patient is obtunded. There is no evidence that 
activated charcoal or cathartics significantly reduce methanol ab­
sorption.
Formate’s diffusion across cell membranes, particularly in the optic 
nerve, is facilitated by a low systemic pH; hence, therapy should 
include partial correction of acidosis via direct alkalinization. Intrave­
nous sodium bicarbonate therapy, which is aimed at reversing 
acidosis (by titrating the blood pH) to avert circulatory collapse and
□  With methanol poisoning, 
substantial treatment delays may 
occur because the clinician is 
falsely reassured by the initial 
lack of severe symptoms.
□  Intravenous sodium bicarbonate 
therapy should be considered if 
the blood pH is below 7.2.
□  Symptoms and history determine 
whether intravenous ethanol 




impede the intracellular penetration of formic acid, should be consid­
ered if the pH is below 7.2. A reduction of blood pH of 0.15 corre­
sponds to a base deficit of 10 mEq/L bicarbonate. The target should 
be a pH in the range of 7.36 to 7.40. Sodium bicarbonate solution 
should be administered slowly to allow the resulting carbon dioxide to 
dissipate via hyperventilation. Sodium overload is a constant hazard 
of sodium bicarbonate therapy, and electrolytes must be monitored 
frequently.
In cases of suspected methanol exposure, the following are indica­
tions for starting an intravenous ethanol infusion: a blood methanol 
level of greater than 20 mg/dL; a history of ingesting more methanol 
than 0.4 mL/kg body weight; any ingestion history, with delayed 
access to toxicologic testing; or metabolic acidosis with otherwise 
unexplained elevated anion and osmolar gaps, especially if eye 
symptoms are present. Ethanol, usually as a 10% solution (10 ml. of 
100% ethanol in 90 ml_ of 5% aqueous dextrose), is first administered 
intravenously in a loading dose of approximately 7.5 to 10 mL/kg over 
20 to 60 minutes. If the patient is conscious, oral loading doses can 
be given since intravenous doses may be painful.
The subsequent ethanol infusion rate varies with the patient’s ethanol 
metabolism and should be adjusted to keep the blood ethanol level 
between 100 and 150 mg/dL. Typically, rates between 0.8 to
1.4 mL/kg/hr suffice. In chronic alcoholics and during hemodialysls(see 
paragraph below), higher rates may be required. Infusions are contin­
ued until the methanol level drops below 20 mg/dL.
Criteria for combined ethanol infusion and hemodialysis include 
visual disturbance, or a methanol level exceeding 50 mg/dL, or a 
severe acidosis unresponsive to intravenous bicarbonate. Peritoneal 
dialysis is less effective than hemodialysis in clearing methanol from 
the blood. During hemodialysis, ethanol infusions should not only 
continue, but also should be increased slightly to compensate for the 
increased ethanol clearance. Even during dialysis, the target blood 
ethanol concentration should remain at 100 to 150 mg/dL.
An adjunctive treatment for methanol poisoning is the administration 
of folate (in the form of folic acid or folinic acid) to increase the 
conversion of formate to carbon dioxide and water. Folate administra­
tion is considered safe and may be efficacious if the patient is folate- 
deficient. Suggested dosage regimens include folic acid, 50 to 70 
milligram (mg) intravenously every 4 hours for the first 24 hours of 
treatment, orfolinicacid (also known as leucovorin, Citrovorum factor, 
or 5-formyl-5,6,7,8-tetrahydrofolate), 1 to 2 milligram per kilogram 
(mg/kg) intravenously every 4 to 6 hours. Any attempt to replenish 
folic acid stores by administering multiple vitamins is likely to be 
frustrated by their low folate content (typically 1 mg per tablet).
An experimental drug, 4-methylpyrazole, Is being investigated in 
animals and humans. This orally administered drug, which combines 
with the enzyme alcohol dehydrogenase, may replace ethanol as a
12
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safe means to block methanol metabolism while patients are pre­
pared for hemodialysis. Administration of 4-methylpyrazole does not 
appear to add to the patient’s CNS depression as does ethanol. In 
addition, the metabolism of 4-methylpyrazole is more predictable and 
prolonged than is that of ethanol, making administration less difficult 
technically. Currently, 4-methylpyrazole is in a Phase III clinical trial 
In the United States.
Additional information for the case study: Consistent with acute methanol intoxication, the patient’s 
arterial blood gases indicate a pH of 7.25; bicarbonate is 10 mEq/L, pC02 23 mm Hg, and p 0 2 92 mm 
Hg. The blood methanol level is 83 mg/dL.
(8) What type of therapeutic intervention is indicated?
(9) You are a rural practitioner, and the nearest hospital is 90 minutes away by ambulance. Although 
you stock standard intravenous rehydration solutions in your clinic pharmacy and have a “crash 
cart” with standard resuscitative drugs, there is no intravenous ethanol or parenteral folate 
available. There is, however, a liquor store nearby. If vodka is used as a substitute for ethanol, 
explain how you would prepare the ethanol dosing solution.
Chronic Exposure
Because a clearly defined clinical syndrome does not exist for chronic 
methanol exposure, treatment should be symptomatic. Patient man­
agement should include removal from exposure, supportive counsel­
ing, and a consideration of alternative diagnoses.
□  Patients chronically 
exposed to methanol 
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Workplace
Air
□  Currently, EPA does not 
regulate the amount of 
methanol in public 
drinking water supplies.
□  EPA has not promulgated an 
air emission standard for 
methanol.
□  OSHA regulations for worker 
exposures to methanol 
include a requirement that 
skin contact be minimized.
Significant dermal absorption of methanol can occur. Workers using 
methanol should be protected against dermal exposures by engi­
neering controls (e.g., by isolating the work process) and by using 
personal protective equipment (impervious gloves, aprons, boots, 
and other appropriate equipment).
Environment
Air
The U.S. Environmental Protection Agency (EPA) does not have an 
emission standard for methanol. However, under EPA’s generic 
standards for the synthetic organic chemical manufacturing industry, 
all volatile organic chemical (VOC) emissions, including methanol 
releases, are to be kept to a technologically feasible minimum.
Drinking Water
Methanol is volatile at room temperature and has an odor threshold 
at approximately 100-250 ppm concentration in air. The Occupa­
tional Safety and Health Administration (OSHA) maintains a work­
place limit for airborne exposures to methanol of 200 ppm (as an 8- 
hourTWA) and 250 ppm for short-term (15-minute) excursions not to 
exceed four such excursions in an 8-hour day (Table 1). Identical 
standards are recommended by ACGIH and NIOSH. The odor of 
methanol may not be perceived by some persons until levels exceed 
acceptable workplace limits. Concentrations exceeding 25,000 ppm 
are considered “immediately dangerous to life or health” (I.e., they 
may result in irreversible health effects or impair the ability of an 
individual to escape from the exposure environment). In general, 
airborne exposures can be controlled through engineering measures 
or by appropriate personal protective equipment or both.
Neither EPA nor the states maintain standards for methanol in 
drinking water.
Methanol Toxicity
Table 1. Standards and regulations for methanol
Agency* Focus Level Comments
OSHA Air-workplace 200 ppm 
250 ppm
Regulation: PEL* (8-hrTW A«) 
Regulation: PEL (STEL11)
NIOSH Air-workplace 200 ppm 
250 ppm
Advisory: REL" (8 -h rT W A ) 
Advisory: REL (STEL)
ACGIH Air-workplace 200 ppm 
250 ppm






Covered under the “best available 
technology” clause for volatile 
organic chemical emissions from 
new or modified facilities.
FDA Food N/A Approved only as an “indirect food 
additive” (i.e., in food packaging 
adhesives).
* ACGIH = American Conference of Governmental Industrial Hyglenists; EPA = Environmental Protection 
Agency; FDA = Food and Drug Administration; NIOSH = National Institute for Occupational Safety 
and Health; OSHA = Occupational Safety and Health Administration
t PEL (Permissible Exposure Limit) = highest level of methanol in air to which a worker may be exposed 
during a normal workshift.
5 TW A (Time-Weighted Average) = time-weighted average concentration for a normal 8-hour workday 
and 40-hour workweek to which nearly all workers may be repeatedly exposed.
11 STEL (Short-Term Exposure Limit) = usually a 15-minute sampling period. In the case of methanol, not 
to exceed four 5-minute excursions in an 8-hour workday, with at least 1 hour between excursions.
** REL (Recommended Exposure Limit) = highest recommended level of methanol in air to which a 
worker may be exposed during a normal workshift.
n  TLV (Threshold Limit Value) = exposure guideline recommended by ACGIH.
15
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Sources of Information
More information on the adverse effects of methanol and treating and managing cases of exposure to methanol 
can be obtained from ATSDR, your state and local health departments, and university medical centers. Case 
Studies in Environmental Medicine: Methanol Toxicity is one of a series. For other publications in this series, 
please use the order form on the back of page 23. For clinical inquiries, contact ATSDR, Division of Health 
Education and Promotion, Office of the Director, at (404) 639-6204.
Answers to Pretest Questions and Challenge Questions
Pretest questions are on page 1. Challenge questions begin on page 2.
Answers to Pretest
(a) Acute visual loss in this age group can occur with central retinal artery or vein occlusion, internal carotid 
emboli, vitreous hemorrhage, retinal/macular hemorrhage, retinal detachment, temporal arteritis, cerebro­
vascular accidents of the posterior circulation, acute angle-closure glaucoma, idiopathic optic neuritis, head 
trauma, and carbon monoxide and methanol poisoning. Of these conditions, only cerebrovascular events, 
head trauma, temporal arteritis, and carbon monoxide and methanol poisoning commonly affect vision 
bilaterally. Other symptoms such as hyperpnea, and later, Kussmaul breathing, are indicative of acidosis 
(see page 10 for a differential diagnosis of acidosis). The patient also manifests signs of inebriation. Methanol 
poisoning could account for all of these effects.
(b) The following information should be sought in any occupational or avocational history: (1) a full description 
of the activity in question, with identification of all chemical products used (including ethanol) either by 
chemical or trade name; (2 ) documentation of potential routes of exposure including inhalation, skin contact, 
and ingestion; and (3) type of ventilation employed and use of personal protective equipment.
(c) Confirmation of suspected methanol poisoning should take place in an emergency department or inpatient 
setting with rapid laboratory tests and the opportunity for prompt therapeutic intervention. Physicians with 
special expertise who might be consulted in this case include clinical toxicologists, nephrologists, and 
ophthalmologists. In geographic areas with restricted access to specialists or with exposures of question­




(d) The clinical findings and the acknowledged methanol exposure (see Challenge question 2, page 4) are 
indicative of methanol intoxication of potentially life-threatening severity. Appropriate therapeutic interven­
tions for methanol intoxication include intravenous ethanol infusion, sodium bicarbonate and folate 
administration, and hemodialysis.
In addition, the patient should receive psychosocial care for his substance abuse tendencies. Referral to a 
substance abuse program is appropriate.
Answers to Challenge Questions
(1) In emergency situations, the most complete and up-to-date information is usually available through a 
regional poison control center. Common reference books that contain information on the chemical 
composition of consumer and commercial products include Gosselin’s Clinical Toxicology of Commercial 
Products and Sax’s Dangerous Properties of Industrial Materials, among others. Many local hospital 
emergency departments have access to toxicologic reference information either on microfiche or CD-ROM. 
Some hospital libraries also have access to online clinical toxicology databases.
(2) The patient used a methanol-containing product for an extended period in a small, unventilated room. Thus, 
the inhaled dose alone is significant. The patient also admits to ingesting a small amount of the product. 
Furthermore, as an alcohol abuser, the patient may be folate-deficient, thus increasing his risk of methanol 
toxicity.
(3) Yes, the symptoms and appearance of the patient in the case study do suggest acute methanol intoxication. 
The patient manifests symptoms of inebriation and complains of visual disturbance several hours after the 
start of a significant methanol exposure. He also is showing signs of acidosis. These factors constitute a 
classic presentation for acute methanol intoxication.
(4) The calculated anion gap is 32 (normal: 12 to 16) and the calculated osmolar gap is 30 (normal: less than 
10). These values are consistent with acute methanol intoxication. For calculations, see below.
Anion Gap = (Na+ + K+) -  (Cl' + HCO3')
= (140+ 4 ) - (1 0 2 +  10)
= 1 4 4 -1 1 2  
= 32
Osmolar Gap = Osmolarity (measured) -  (2Na+ + [BUN-s-2.8] + [Glucose+18])
= 320 -  (2 X 140 + [14+2.8] + [90+18])
= 320 -  (280 + 5 + 5)
= 320 -  290 
= 30
(5) The conditions that can produce an elevated anion-gap acidosis are summarized by the mnemonic 
MUDPILES:
M Methanol intoxication 
U Uremia
D Diabetic ketoacidosis 
P Propylene glycol poisoning
I Iron and isoniazid overdoses; inhalants (carbon monoxide, cyanide, hydrogen sulfide)
L Lactic acidosis




(6) Intoxication by the following agents (or accumulation, in the case of acetone in diabetic or alcoholic 
ketoacidosis) produces an elevated osmolar gap: methanol, ethanol, ethylene glycol, acetone, and 
isopropanol.
Although several drugs can potentially contribute to the osmolar gap (e.g., salicylates, paraldehyde, and 
chloral hydrate), they are rarely present at concentrations sufficient to raise osmolarity.
(7) A neuro-ophthalmologic examination of the patient might reveal several findings. Results of examination of 
visual fields, as determined by perimetry, typically indicate central scotomata early in the course of methanol 
poisoning (soon after onset of acidosis), with peripheral constriction of visual fields a late finding. Dilated, 
unreactive pupils and dim vision are characteristic. The result can be bilateral blindness, which is usually 
permanent.
(8) See the answer to Pretest question (d).
(9) One-hundred proof vodka is actually 50% ethanol by volume. A loading dose equivalent to the required
7.5 mL/kg of 10% ethanol can be achieved with vodka as follows: In a 70 kg person, a total of 525 mL of 
10% ethanol would be needed (7.5 ml_/kg * 70 kg = 525 mL).
5 2 5  m L x 1 o% = X m L x 5 0 %
52.5 mL = 0.5X mL
X = 105 mL of the 50% ethanol
In summary, 105 mL of 50% ethanol with 5% dextrose in water added to total 525 mL will produce a 10% 
ethanol solution. (See Treatment and Management, page 11.) This quantity of vodka or an equivalent amount 








Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding continuing medical education (CME) credits and continuing education units 
(CEU) is a posttest score of 70% or better.
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (IACET) to sponsor continuing education units for other health 
professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in Category 1 of the Physician’s Recognition Award of the American Medical Association and 0.1 hour of 
CEU for other health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for 
1 prescribed hour by the American Academy of Family Physicians. (Term of Approval: beginning January 1992.) 
For specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for one hour per issue of ACEP Category I credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Health Nurses (AAOHN). This independent study offering has 
been approved for 1.3 contact hours (term of aproval beginning July 19,1996) by AAOHN, which is accredited 
as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission 
on Accreditation. For current approval status, contact AAOHN at (404) 262-1162.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per 3 Case Studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEU), complete the Posttest on page 22 in the manner shown in 
the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?
t fatigue alcoholc. grapefruit 
(§Psunlight 
e. sleep
After you have finished the Posttest, please transfer your answers to the answer sheet on page 23 and complete the 
evaluation on the lower half and the information and case-study requests on the back of that page. Remove the page 
from the booklet and fold, staple, and mail it to Continuing Education Coordinator, Agency for Toxic Substances and 
Disease Registry, Division of Health Education and Promotion, E33,1600 Clifton Road, NE, Atlanta, GA 30333. Your 
confidential test score will be returned with an indication of where the correct answers can be found in the text. 
Validation of earned CME credit and CEU will also be forwarded to you, and your name, if requested, will be placed 




Circle all correct answers and transfer your answers to page 23.




d. alternative motor fuels
e. solid canned heat
2. Which of the following statements are true?
a. Methanol is poorly absorbed on dermal contact.
b. Ethanol can prolong methanol’s half-life in the body.
c. Folinic acid, a  metabolite of methanol, is responsible for blindness caused by methanol poisoning.
d. Metabolic acidosis in a methanol-poisoned patient is most likely due to the formic acid metabolite.
e. Severe methanol poisoning is characterized by initial inebriation and delayed-onset visual 
disturbances.




d. oxalate crystals in the urine
e. an increased osmolar gap




d. ethylene glycol poisoning
e. renal failure
5. Which of the following statements are true?
a. The accumulation of formaldehyde is responsible for many symptoms of methanol toxicity.
b. Alcohol dehydrogenase has a  greater affinity for ethanol than for methanol.
c. Folate administration is an adjunct therapy for methanol toxicity.
d. Folate acts by enhancing the conversion of formic acid to carbon dioxide and water.
e. The higher the methanol dose, the more rapid its conversion to formaldehyde.
6. Treatment of acute methanol intoxication might include which of the following treatments?
a. salicylate therapy
b. ethanol infusion
c. sodium bicarbonate therapy
d. activated charcoal
e. hemodialysis
7. A patient’s laboratory findings include the following data measured in serum: sodium 142 mEq/L; potassium  
4.2  mEq/L; ionized calcium 4 .0  mg/dL; chloride 101 mEq/L; bicarbonate 15 mEq/L; glucose 98 mg/dL;
BUN 15 mg/dL. Which of the following statements are true?
a. This patient’s anion gap is 30.
b. This patient’s anion gap is within the normal range.
c. The anion gap is elevated in cases of renal failure.
d. This patient’s anion gap cannot be calculated from these data.
e. This patient’s anion gap is abnormal.








CASE STUDIES IN ENVIRONMENTAL MEDICINE: METHANOL TOXICITY
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 22 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency for Toxic Substances and Disease Registry, Division of Health Education and Promotion, E33, 1600 
Clifton Road, Atlanta, GA 30333.
1 . a b c d e
2 . a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire




1 . As a result of completing this monograph, I will be able to:
Explain why methanol may be a health hazard.
Describe the factors contributing to methanol toxicity.
Identify potential environmental and occupational sources of 
exposure to methanol.
Identify evaluation and treatment protocols for persons exposed 
to methanol.
List sources of information on methanol.
2. The monograph addressed the objectives printed on the 
inside front cover.
3. I am more likely to ask patients questions about possible 
environmental exposures as a result of reading this monograph.
4. Independent study was an effective learninging method for
the content.
5. How much time (in minutes) was required to read this monograph 
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